Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer?

被引:44
|
作者
Jones, Tiffanie [1 ]
Neboori, Hanmanth [2 ]
Wu, H. [2 ]
Yang, Qifeng [3 ]
Haffty, Bruce G. [2 ]
Evans, Susan [1 ]
Higgins, Susan [1 ]
Moran, Meena S. [1 ]
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] UMDNJ Robert Wood Johnson Sch Med, New Brunswick, NJ USA
[3] Shangdong Univ, Jinan, Peoples R China
关键词
TRIPLE-NEGATIVE PHENOTYPE; BASAL-LIKE SUBTYPE; MOLECULAR SUBTYPE; CONSERVATION THERAPY; AXILLARY DISSECTION; HORMONE-RECEPTOR; SURVIVAL; OUTCOMES; BIOPSY; WOMEN;
D O I
10.1245/s10434-013-2994-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer subtypes (BCS) determined from immunohistochemical staining have been correlated with molecular subtypes and associated with prognosis and outcomes, but there are limited data correlating these BCS and axillary node involvement. This study was conducted to assess whether BCS predicted for nodal metastasis or was associated with other clinicopathologic features at presentation. Patients with stage I/II disease who underwent breast-conserving surgery and axillary surgical assessment with available tissue blocks underwent a institutional pathological review and construction of a tissue microarray. The slides were stained for estrogen receptor, progesterone receptor, and HER-2/neu (HER-2) for classification into BCS. Nodal involvement and other clinicopathologic features were analyzed to assess associations between BCS and patient and tumor characteristics. Outcomes were calculated a function of BCS. The study cohort consisted of 453 patients (luminal A 48.6 %, luminal B 16.1 %, HER-2 11.0 %, triple negative 24.2 %), of which 22 % (n = 113) were node positive. There were no significant associations with BCS and pN stage, node positivity, or absolute number of nodes involved (p > 0.05 for all). However, there were significant associations with subtype and age at presentation (p < 0.001), method of detection (p = 0.049), tumor histology (p < 0.001), race (p = 0.041), and tumor size (pT stage, p < 0.001) by univariate and multivariate analysis. As expected, 10-year outcomes differed by BCS, with triple negative and HER-2 subtypes having the worse overall (p = 0.03), disease-free (p = 0.03), and distant metastasis-free survival (p < 0.01). There is a significant association between BCS and age, T stage, histology, method of detection, and race, but no associations to predict nodal involvement. If additionally validated, these findings suggest that BCS may not be a useful prognostic variable for influencing regional management considerations.
引用
收藏
页码:2866 / 2872
页数:7
相关论文
共 50 条
  • [41] A prognostic tool to predict fatigue in women with early-stage breast cancer undergoing radiotherapy
    Courtier, N.
    Gambling, T.
    Enright, S.
    Barrett-Lee, P.
    Abraham, J.
    Mason, M. D.
    BREAST, 2013, 22 (04) : 504 - 509
  • [42] Prognostic Influence of Internal Mammary Node Drainage in Patients with Early-stage Breast Cancer
    Lukesova, Lucie
    Vrana, David
    Svach, Ivan
    Zlamalova, Nora
    Gatek, Jiri
    Vlachova, Zuzana
    Matzenauer, Marcel
    Koranda, Pavel
    Hruzova, Klara
    Tichy, Tomas
    Melichar, Bohuslav
    ANTICANCER RESEARCH, 2016, 36 (12) : 6641 - 6646
  • [43] Prognostic implication of the primary tumor location in early-stage breast cancer: focus on lower inner zone
    Yang, Jiqiao
    Tang, Shenli
    Zhou, Yuting
    Qiu, Juanjuan
    Zhang, Juying
    Zhu, Sui
    Lv, Qing
    BREAST CANCER, 2018, 25 (01) : 100 - 107
  • [44] Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age ≤35)
    Goksu, Sema Sezgin
    Tastekin, Didem
    Arslan, Deniz
    Gunduz, Seyda
    Tatli, Ali Murat
    Unal, Dilek
    Salim, Derya
    Guler, Tunc
    Coskun, Hasan Senol
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6665 - 6668
  • [45] Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
    Alhudiri, Inas
    Nolan, Christopher
    Ellis, Ian
    Elzagheid, Adam
    Green, Andrew
    Chapman, Caroline
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (01) : 143 - 153
  • [46] Axillary ultrasonography for early-stage invasive breast cancer
    Jiang, Karen
    Ma, Crystal
    Yang, Yuwei
    Mckevitt, Elaine
    Pao, Jin-Si
    Warburton, Rebecca
    Dingee, Carol
    Bremang, Jieun Newman-
    Deban, Melina
    Bazzarelli, Amy
    AMERICAN JOURNAL OF SURGERY, 2024, 231 : 86 - 90
  • [47] Avoiding Locoregional Overtreatment in Older Adults With Early-Stage Breast Cancer
    Lorentzen, Eliza H.
    Minami, Christina A.
    CLINICAL BREAST CANCER, 2024, 24 (04) : 319 - 327
  • [48] Factors Associated with Variance in Compliance with a Sentinel Lymph Node Dissection Quality Measure in Early-Stage Breast Cancer
    Olaya, Windy
    Wong, Jan
    Morgan, John W.
    Truong, Caitlyn
    Roy-Chowdhury, Sharmila
    Kazanjian, Kevork
    Lum, Sharon
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S297 - S302
  • [49] The prognosis of early-stage breast cancer in extremely young female patients
    Chung, Wei-Pang
    Lee, Kuo-Ting
    Chen, Ya-Ping
    Hsu, Ya-Ting
    Loh, Zhu-Jun
    Huang, Chien-Chang
    Hsu, Hui-Ping
    MEDICINE, 2021, 100 (01) : E24076
  • [50] The role of tumor phenotype in the surgical treatment of early-stage breast cancer
    Rooney, Marguerite M.
    Thomas, Samantha M.
    Taskindoust, Mahsa
    Greenup, Rachel A.
    Rosenberger, Laura H.
    Hwang, Shelley
    Plichta, Jennifer K.
    AMERICAN JOURNAL OF SURGERY, 2023, 225 (01) : 84 - 92